Showing results (61-70 of 354) with videos related to
Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomesYair Lotan, Jeffrey A Cadeddu, J Jack Lee, et al.Cancer Research|July 20, 2006
RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoAZheng D Liang, Scott M Lippman, Tsung-Teh Wu, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
The cost of prostate cancer chemoprevention: a decision analysis modelRobert S Svatek, J Jack Lee, Claus G Roehrborn, et al.Cancer Immunology Research|August 14, 2019
Microsatellite-Stable Tumors with High Mutational Burden Benefit from ImmunotherapyAaron M Goodman, Ethan S Sokol, Garrett M Frampton, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 12, 2018
Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancerDuc Ha, Andrew L Ries, Peter J Mazzone, et al.Molecular Oncology|January 25, 2023
Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real-world precision-medicine populationShai Rosenberg, Gil Ben Cohen, Shumei Kato, et al.Cancer|January 12, 2008
Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysisRobert S Svatek, J Jack Lee, Claus G Roehrborn, et al.Seminars in Oncology|December 1, 2019
Helping the cardio-oncologist: from real life to guidelinesSaro H Armenian, Wojciech Jurczak, Joseph R Carver, et al.Mayo Clinic Proceedings|June 6, 2008
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trialsEdith A Perez, Maria Koehler, Julie Byrne, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2005
Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisitedEric A Klein, Catherine M Tangen, Phyllis J Goodman, et al.Pageof 36